Benmelstobart combined with Bevacizumab and chemotherapy Clinical Trials

1 actively recruiting trial

Also known as: Radiotherapy

Pipeline

Phase 2: 1

Top Sponsors

Xinqiao Hospital of Chongqing1

Indications

NSCLC Stage IV Without EGFR/ALK Mutation1
Lung Cancer1
Cancer1

Other1 trial

Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.